Press release
Liver Fibrosis Patient Pool Analysis Market to Reach USD 1.94 Billion by 2034
Liver Fibrosis Patient Pool Analysis
Download Full PDF Sample Copy of Market Report @ https://exactitudeconsultancy.com/request-sample/71980
Market Summary
The Liver Fibrosis Patient Pool Analysis Market is expanding rapidly as liver fibrosis-defined by excessive extracellular matrix buildup due to chronic liver injury-becomes a growing global health burden. Key contributors include NAFLD/NASH, chronic hepatitis B and C, alcohol-associated liver disease, autoimmune hepatitis, and metabolic disorders.
Early-stage fibrosis is often asymptomatic, making accurate epidemiological assessment crucial for healthcare systems and pharmaceutical developers. The rise of non-invasive diagnostics, such as FibroScan® (transient elastography), MR elastography, serological fibrosis biomarkers (FIB-4, ELF Test), and AI-driven risk stratification tools, is enabling more reliable prevalence estimation.
North America and Europe lead in adoption of fibrosis staging technologies and liver disease registries, while Asia-Pacific is experiencing the fastest rise in patient pool size, driven by high hepatitis prevalence and metabolic syndrome growth.
Key Takeaways
• 2024 Market Size: USD 1.12 Billion
• 2034 Forecast: USD 1.94 Billion
• CAGR: 5.8% (2025-2034)**
• NAFLD/NASH remains the largest contributor to global fibrosis burden
• Non-invasive staging tools accelerating patient pool identification
• Asia-Pacific continues to see the sharpest growth in fibrosis cases
Market Drivers
• Increasing prevalence of metabolic disorders (obesity, diabetes) linked to NAFLD/NASH
• High global burden of chronic hepatitis B and C
• Growing alcohol consumption trends affecting liver health
• Advancements in non-invasive fibrosis assessment technologies
• Expansion of national liver disease registries and real-world data systems
Segmentation Snapshot
By Etiology
• NAFLD/NASH (Largest Segment)
• Alcohol-Related Liver Disease
• Hepatitis B
• Hepatitis C
• Autoimmune Hepatitis
• Genetic/Metabolic Liver Disorders
• Drug-Induced Liver Injury
By Diagnostic Method
• Non-Invasive Fibrosis Tests
o Transient Elastography (FibroScan®)
o MR Elastography
o Serum Biomarkers (FIB-4, APRI, ELF Score)
o AI/ML-Based Diagnostics
• Liver Biopsy (Gold Standard but Declining)
By Data Source
• Hospital & Specialty Liver Clinics
• National Liver Registries
• Insurance Claims & EHR Databases
• Population Health Studies
• Real-World Evidence (RWE) Platforms
By End User
• Government Health Agencies
• Hospitals & Academic Research Centers
• Pharmaceutical Companies
• CROs & Epidemiology Firms
• Real-World Data (RWD) Analytics Providers
By Region
• North America (Largest Market)
• Europe
• Asia-Pacific (Fastest Growing)
• Latin America
• Middle East & Africa
Explore Full Report here: https://exactitudeconsultancy.com/reports/71980/liver-fibrosis-patient-pool-analysis-market
Recent Developments
• AI-driven fibrosis detection tools showing higher accuracy in early diagnosis.
• Expanding use of MR elastography in clinical trials for NASH.
• National registries integrating fibrosis staging for population surveillance.
• Increased collaboration between hepatology centers and RWE platforms.
Expert Quote - Irfan Tamboli, Business Development Executive
"Liver fibrosis is emerging as a major global health challenge, driven largely by NAFLD and metabolic disease. With non-invasive diagnostics becoming mainstream, patient pool estimation is more accurate than ever before."
Conclusion
The Liver Fibrosis Patient Pool Analysis Market will continue expanding through 2034 as lifestyle-related liver diseases rise, diagnostic technologies mature, and real-world epidemiology systems advance. Companies investing in fibrosis staging tools, analytics, and hepatology data platforms are positioned to shape the future of liver disease management.
This report is also available in the following languages : Japanese (肝線維症患者プール分析、市場), Korean (간 섬유증 환자 풀 분석, 시장), Chinese (肝纤维化患者群体分析,市场), French (Analyse du marché des patients atteints de fibrose hépatique), German (Analyse des Patientenpools für Leberfibrose, Markt), and Italian (Analisi del bacino di pazienti affetti da fibrosi epatica, mercato), etc.
Request for a sample of this research report at (Use Corporate Mail ID for Quick Response) @ https://exactitudeconsultancy.com/request-sample/71980
Related Reports
NonAlcoholic Fatty Liver Disease (NAFLD) Patient Pool Analysis, Market
https://exactitudeconsultancy.com/reports/71981/nonalcoholic-fatty-liver-disease-nafld-patient-pool-analysis-market
Severe Hypertriglyceridemia Market
https://exactitudeconsultancy.com/reports/72003/severe-hypertriglyceridemia-market
Liver Cirrhosis Patient Pool Analysis, Market
https://exactitudeconsultancy.com/reports/72041/liver-cirrhosis-patient-pool-analysis-market
North America Biopsy Devices Market
https://exactitudeconsultancy.com/reports/72315/north-america-biopsy-devices-market
About Us
Exactitude Consultancy is a market research & consulting services firm which helps its client to address their most pressing strategic and business challenges. Our market research helps clients to address critical business challenges and also helps make optimized business decisions with our fact-based research insights, market intelligence, and accurate data.
https://bulletin.exactitudeconsultancy.com/
https://www.thehealthanalytics.com/
https://www.analytica.global/
https://www.marketintelligencedata.com/
https://www.marketinsightsreports.com/
https://exactitudeconsultancy.com/
Connect Us:
Irfan Tamboli
PHONE NUMBER +1 (704) 266-3234
EMAIL ADDRESS: sales@exactitudeconsultancy.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Liver Fibrosis Patient Pool Analysis Market to Reach USD 1.94 Billion by 2034 here
News-ID: 4305372 • Views: …
More Releases from Exactitude Consultancy
Diabetic Kidney Disease (DKD) Market to Reach USD 9.87 Billion by 2034
Pune, India - December 2025 - The global Diabetic Kidney Disease (DKD) Market, valued at USD 5.61 billion in 2024, is projected to reach USD 9.87 billion by 2034, growing at a 5.9% CAGR (2025-2034), according to Exactitude Consultancy. Increasing rates of type 2 diabetes, enhanced CKD screening, and strong uptake of SGLT2 inhibitors and RAAS-modulating therapies are steering market expansion.
Download Full PDF Sample Copy of Market Report @ https://exactitudeconsultancy.com/request-sample/71984
Market…
Graves' Ophthalmopathy Market to Grow at a CAGR of 7.4%
Pune, India - Exactitude Consultancy: The global Graves' Ophthalmopathy (GO) Market is projected to grow at a CAGR of 7.4% over the forecast period. Growing prevalence of Graves' disease, improved recognition of thyroid-associated orbitopathy, and the introduction of biologic and immunomodulatory treatment options significantly contribute to market expansion.
Download Full PDF Sample Copy of Market Report
https://exactitudeconsultancy.com/request-sample/72230
Introduction
Graves' Ophthalmopathy-also known as thyroid eye disease (TED)-is an autoimmune inflammatory disorder affecting the orbit…
Rheumatoid Arthritis (RA) Patient Pool Analysis Market to Reach USD 2.74 Billion …
Pune, India - December 2025 - The global Rheumatoid Arthritis (RA) Patient Pool Analysis Market, valued at USD 1.59 billion in 2024, is projected to reach USD 2.74 billion by 2034, growing at a 5.6% CAGR (2025-2034), according to Exactitude Consultancy. Increasing autoimmune disease awareness, expanding use of advanced diagnostics, and rising integration of real-world evidence (RWE) platforms are strengthening RA patient identification and epidemiology modeling across regions.
Download Full PDF…
Fuchs Endothelial Corneal Dystrophy (FECD) Market to Grow at a CAGR of 6.1%
Pune, India - Exactitude Consultancy: The global Fuchs Endothelial Corneal Dystrophy (FECD) Market is projected to grow at a CAGR of 6.1% during the forecast period. Rising prevalence of corneal endothelial dysfunction among older adults, increasing cataract surgery volumes, and technological advancements in corneal transplantation are major contributors to market growth. Emerging regenerative cell therapies and improved imaging capabilities further expand the treatment landscape.
Download Full PDF Sample Copy of Market…
More Releases for Liver
Rising Liver Disease Cases Drive Growth In Liver Metastases Treatment Market Dri …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
How Large Will the Liver Metastases Treatment Market Size By 2025?
The market for treating liver metastases has seen significant growth in the past few years. It is projected to increase from $1.57 billion in 2024 to $1.71 billion in 2025, with a compound annual growth rate (CAGR) of…
LivCare Liver Support
The liver plays a crucial role in maintaining overall well-being, performing essential functions like detoxification, digestion, and metabolism. However, many people overlook the importance of liver health until problems arise. LivCare Liver Support is a premium supplement designed to keep your liver in peak condition. By incorporating this supplement into your daily routine, you can help ensure your liver functions optimally, leading to better overall health.
● Product Name - LivCare…
Liver Cancer Therapeutics Market - Empowering Recovery, Restoring Health: Innova …
Newark, New Castle, USA - new report, titled Liver Cancer Therapeutics Market The report has been put together using primary and secondary research methodologies, which offer an accurate and precise understanding of the Liver Cancer Therapeutics market. Analysts have used a top-down and bottom-up approach to evaluate the segments and provide a fair assessment of their impact on the global Liver Cancer Therapeutics market. The report offers an overview of…
Liver Health Supplements Market Grows Strong as Consumers Adopt Proactive Measur …
Global liver health supplements market was valued at US$ 8.7 Bn in 2021, is growing at an estimated CAGR of 5.8% over the forecast period (2022 - 2030). The liver health supplements market is growing due to the increasing awareness of the importance of liver health and the rise of lifestyle-related liver diseases. The market offers a wide range of supplements that help in improving liver function, supporting liver detoxification,…
Urgent Liver 911 Reviews 2021: Is Urgent Liver 911 Legit?
Urgent Liver 911 by PhytAge Laboratories is a powerful diet that promotes liver function by combining natural minerals and nutrients. The diet is made up of plant and herbal extracts that collectively aid in liver cell protection. While the liver is an important human organ that promotes general health and vitality, most people are unaware that even those who appear to be in good health can be affected by liver…
Liver Extract Power Exporter, Liver Extract Product, Liver Extract Crude, Liver …
Titan Biotech is an ISO 9001:2000 Certified Company, established with an objective of serving Scientific Community and providing good quality of Biological Products, Biotechnology Products, Biological Extracts and their derivatives. Liver Extract Power Exporter is produced from specific fraction of beef liver. Liver Extract is rich in vital nutrients including energy producing B Vitamins and serve as an excellent source of proteins. Liver Extract is capable of stimulating the production…
